Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): An update

Journal of Long-Term Effects of Medical Implants

Volumn 13, Issue 2, 2003, Pages 127-140

  Edlich, Richard F ^a,c   Hill, Lisa G ^a   Williams, Freddie M ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Adult T cell leukemia lymphoma; HTLV I associated myelopathy tropical spastic paraparesis; Human immunodeficiency virus; Human T cell lymphotrophic virus I; Human T cell lymphotrophic virus II; Public health initiatives; Seroprevalence; Transmission

Indexed keywords

CELLS; DISEASES; OPERATING ROOMS; VIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS (HIV);

IMPLANTS (SURGICAL);

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHRONIC DISEASE; DERMATITIS; DISEASE ASSOCIATION; EPIDEMIC; FATALITY; HIGH RISK POPULATION; HOSPITAL PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; OPERATING ROOM; RETROVIRUS; REVIEW; SEROPREVALENCE; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; UVEITIS; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; AGED; CHILD; FEMALE; HTLV-I INFECTIONS; HUMANS; MALE; MIDDLE AGED; PUBLIC HEALTH; WORLD HEALTH;

EID: 0038665170     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v13.i2.70     Document Type: Review

References (133)

1. Gallo RC, Thomson MM. Introduction. In: Höllsberg P, Hafler DA, editors. Human T-Cell Lymphotrophic Virus Type I. New York: Wiley, 1996.
2. Jarrett WF, Martin WB, Crighton GW, Dalton RG, Stewart MF. Leukemia in the cat. Transmission experiments with leukemia (lymphosarcoma). Nature 1964; 202:566-567.
3. Hardy WD Jr, Hess AW, Macewen EG, McClelland AJ, Zuckerman EE, Essex M, Cotter SM, Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res 1976; 36:582-588.
4. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970; 226:1211-1213.
5. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977; 270:347-349.
6. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-7419.
7. de Thé G, Gessain A, Gazzolo L, Robert-Guroff M, Najberg G, Calender A, Peti M, Brubaker G, Bensliman A, et al. Comparative seroepidemiology of HTLV-I and HTLV-II in the French West Indies and some African countries. Cancer Res 1985; 45:4633s-4636s.
8. Essex M, Mclanes MF, Tachibana N, Francis DP, Lee TH. Seroepidemiology of human T-cell leukemia virus in relation to immunosuppression and the acquired immunodeficiency syndrome. In: Gallo RC, Essex M, Gross L, editors. Human T-Cell Leukemia/Lymphoma Virus. New York: Cold Spring Harbor Laboratory, 1984: 355-362.
9. Hinuma Y, Komodo H, Chosa T, Kondo T, Kohakura M, Takenaka T, Kikuchi M, Ichimaru M. Antibodies to adult T-cell leukemia-virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide seroepidemiologic study. Int J Cancer 1982; 29:631-635.
10. Manzari V, Gradilone A, Barillari G, Zani M, Collalti E, Pandolfi F, De Rossi G, Liso V, Babbo P, Robert-Guroff M, et al. HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population. Int J Cancer 1985; 36:557-559.
11. Sugiyama H, Doi H, Yamaguchi K, Tsuji Y, Miyamoto T, Hino S. Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol 1986; 20:253-260.
12. Kaplan JE, Khabbaz RF. HTLV-I: newest addition to blood donor screening. Am Fam Phys 1989; 40:189-195.
13. Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, Blattner WA, Gallo RC. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986; 255:3133-3137.
14. Khabbaz RF, Darrow WW, Lairmore M, et al. Prevalence of antibody to HTLV-I among 1415 female prostitutes in the United States. Proceedings of the IVth International Conference on AIDS; 88; Stockholm, Sweden.
15. Minamoto GY, Gold JW, Scheinberg DA, Hardy WD, Chein N, Zuckerman E, Reich L, Dietz K, et al. Infection with human T-cell leukemia virus type-I in patients with leukemia. N Engl J Med 1988; 318:219-222.
16. Kelen GD, DiGiovanna TA, Lofy L, Junkins E, Stein A, Sivertson KT, Larimore M, Quinn TC. Human T-lymphotropic virus (HTLV-I-II) infection among patients in an inner-city emergency department. Ann Intern Med 1990; 113:368-372.
17. Williams AE, Fang CT, Slamon DJ, Poiesz BJ, Sandler SG, Darr WF 2nd, Shulman G, McGowan EI, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 1988; 240:643-646.
18. Centers for Disease Control. Current trends Human T-lymphotropic virus type-I screening in volunteer blood donors - United States, 1989. MMWR 1990; 39(50);915, 921-924.
19. Blayney DW, Blattner WA, Robert-Guroff M, Jaffe ES, Fisher RI, Bunn PA Jr, Patton MG, Rarick HR, et al. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA 1983; 250:1048-1052.
20. de Thé G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 1993; 9:381-386.
21. Komuro A, Hayami M, Fujii H, Miyahara S, Hirayama M. Vertical transmission of adult T-cell leukemia virus. Lancet 1983; 1(8318):240.
22. Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, et al. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 1985; 76:474-480.
23. Kinoshita K, Hino S, Amagasaki T, Ikeda S, Yamada Y, Suzuyama J, Momita S, Toriya K, et al. Demonstration of adult T-cell leukemia virus antigen in milk from three seropositive mothers. Gann 1984; 75:103-105.
24. Yamanouchi K, Kinoshita K, Moriuchi R, Katamine S, Amagasaki T, Ikeda S, Ichimaru M, Miyamoto T, et al. Oral transmission of human T-cell leukemia virus type-I into a common marmoset as an experimental model for milk-borne transmission. Jpn J Cancer Res 1985; 76:481-487.
25. Osame M, Miyata K, Nagat Y, Sonoda S, Takahashi K, Takezaki T, Oki T, Kawakami K, et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The Mother-To-Child Transmission Study Group. Int J Cancer 1991; 49:673-7.
26. Ando Y, Nakano S, Saito K, Shimamoto I, Ichijo M, Toyama T, Hinuma Y. Transmission of adult T-cell leukemia retrovirus (HTLV-I) from carrier mother to child: comparison of bottle- with breast-fed babies. Jpn J Cancer Res 1987; 78:322-324.
27. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis 1986; 154:851-857.
28. Nakano S, Ando Y, Ichijo M, Moriyama I, Saito S, Sugamura K, Hinuma Y. Search for possible routes of vertical and horizontal transmission of adult T cell leukemia virus. Gann 1984; 75:1044-1045.
29. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, Cranston B, Hanchard B, et al. Sexual transmission of human T-lymphotrophic virus type I (HTLV-I). Ann Intern Med 1989; 111:555-560.
30. Bartholomew C, Saxinger WC, Clark JW, Gail M, Dudgeon A, Mahabir B, Hull-Drysdale B, Cleghorn F, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 1987; 257:2604-2608.
31. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversions in recipients. Vox Sang 1984; 46:245-253.
32. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, Hanchard B, Blattner WA. A prospective study of transmission of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51:886-891.
33. Osame M, Janssen R, Kubota H, Nishitani H, Igata A, Nagataki S, Mori M, Goto I, et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990; 28:50-56.
34. Gout O, Baulac M, Gessain A, Semah F, Peries J, Cabron C, Foucault-Fretz C, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322:383-388.
35. Chen Y-C, Wang C-H, Su I-J, Hu C-Y, Chou M-J, Lee T-H, Lin D-T, Chung T-Y, et al., Infection of human T cell leukemia virus Type I and development of human T cell leukemia/lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood 1989; 74:388-394.
36. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 224:471-475.
37. Kataoka R, Takehara N, Iwahar Y, Ohtsuhi Y, Hoshion DH, Miyoshi I. Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood 1990; 76:1657-1661.
38. nd General Meeting of the American Society of Microbiology; 92 May 26-30 New Orleans, Louisiana.
39. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR Morb Mortal Wkly Rep 2s 1987; 36:3-18.
40. Tajima K. The 4th nationwide study of adult T-cell leukemia/lymphoma (ATLL) in Japan: estimates of risk of ATLL and its geographical and clinical features. The T- and B-cell malignancy study group. Int J Cancer 1990; 45:237-243.
41. Gessain A, Yanagihara R, Franchini G, et al., Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc Natl Acad Sci USA 1991; 88:7694-7698.
42. Murai K, Tachibana N, Shioiri S, Shishime E, Okayama A, Ishizaki J, Tsuda K, Mueller N. Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. J Acquir Immune Defic Syndr 1990; 3:1006-1009.
43. Morgan O, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989; 2:1184-1186.
44. Ijiehi S, Matsuda T, Maruyama I, Izumihara T, Kojima K, Niimura T, Maruyama Y. Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 1990; 49:718-721.
45. La Grenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336:1345-1347.
46. Edlich RF, Arnette JA, Williams FN. Global epidemic of human t-cell lymphotropic virus type-1 (HTLV-I). J Emerg Med 2000; 18:109-119.47.
47. Bartholomew C, Blattner W, Cleghom P. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet 1987; 2:1469.
48. Page JB, Lai S, Chitwood DD, Klimas NG, Smith PC, Fletcher MA. HTLV-I/II seropositivity and death from AIDS among HIV-I seropositive intravenous drug users. Lancet 1990; 335:1439-1441.
49. Osame M, Igata A, Matsumoto M, Kohka M, Usuku K, Izumo S. HTLV-I-associated myelopathy (HAM), treatment trials, retrospective survey, and clinical and laboratory findings. Hematol Rev 1990; 3:271-284.
50. Osame M, Igata A, Usuku K, Rosales L, Matsumoto M. Mother-to-child transmission in HTLV-I-associated myelopathy. Lancet 1987; 1:106.
51. Osame M, Janssen R, Kubota H, Nishitani H, Igata A, Nagataki S, Mori M, Toto I, et al. Nationwide survey of HTLV-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990; 28:51-56.
52. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotrophic virus type I and adult T-cell leukemia-like cells. Ann Neurol 1987; 21:117-122.
53. Grimaldi LM, Roos RP, Devare SG, Casey JM, Maruo Y, Hamada T, Tashiro K. HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Ann Neurol 1988; 24:727-731.
54. Saito T, Osame M, Usuku K, Izumo S, Matsumoto M, Igata A. Oligoclonal immunoglobulin bands and HTLV-I-associated myelopathy: detection by agarose isoelectric focusing, transfer to cellulose nitrate membrane, and immunoperoxidase staining. In: Roman G, Vernant JC, Osame M, editors. HTLV-I and the Nervous System. New York: Alan R Liss, 1989: 315-318.
55. Nomoto M, Utatsu Y, Soejima Y, Osame M. Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurology 1991; 41:457.
56. Imamura A, Kitagawa T, Ohi Y, Osame M. Clinical manifestation of human T-cell lymphotrophic virus type-I-associated myelopathy and vesicopathy. Urol Int 1991; 46:149-153.
57. Newton M, Cruickshank K, Miller D, Dalgleish A, Rudge P, Clayden S, Moseley I. Antibody to human T-cell lymphotrophic virus type I in West Indian-born UK residents with spastic paraparesis. Lancet 1987; 1:415-416.
58. Kira J, Minato S, Itoyama Y, Goto I, Kato M, Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data. J Neurol Sci 1988; 87:221-223.
59. Furukawa Y, Osame M, Une F. Magnetic resonance imaging abnormalities in HTLV-I-associated myelopathy (HAM). In: Roman G, Vernant JC, Osame M, editors. HTLV-I and the Nervous System. New York: Alan R Liss, 1989: 393-396.
60. Tashiro K, Maruo Y, Shiokawa T, et al. MS-like features in patients with HTLV-I-associated myelopathy. In: Roman G, Vernant JC, Osame M, editors. HTLV-I and the Nervous System. New York: Alan R Liss, 1989: 209-212.
61. Arimura K, Rosales R, Osame M, Igata M. Clinical electro-physiologic studies of HTLV-I-associated myelopathy. Arch Neurol 1987; 44:609-612.
62. Shibasaki H, Endo C, Kuroda Y, Kakigi R, Oda K, Komine S. Clinical picture of HTLV-I-associated myelopathy. J Neurol Sci 1988; 87:15-24.
63. Kakigi R, Shibasaki H, Kuroda Y, Endo C, Oda K, Ikeda A, Hashimoto K. Multimodal evoked potentials in HTLV-I-associated myelopathy. J Neurol Neurosurg Psychiatry 1988; 51:1094-1096.
64. Ludolf AC, Hugon J, Roman GC, Spencer PS, Schoenberg BS. A clinical neurophysiologic study of tropical spastic paraparesis. Muscle Nerve 1988; 11:392-397.
65. Cruickshank JK, Rudge P, Dalgleish AG, Newton M, McLean BN, Barnard RO, Kendall BE, Miller DH. Tropical spastic paraparesis and human T-cell lymphotrophic virus type 1 in the United Kingdom. Brain 1989; 112:1057-1090.
66. Castillo JL, Cartier L, Araya F, Verdugo R, Mora C, Gibbs C. Evoked potential abnormalities in progressive spastic paraparesis associated to HTLV-I. Acta Neurol Scand 1993; 83:151-154.
67. Tomita I, Shibayama K, Matsuo H, Kinoshita I, Tsujihata M, Nagataki S. Central motor conduction time in patients with HTLV-I-associated myelopathy. Acta Neurol Scand 1989; 79:419-427.
68. Arimura Y, Arimura K, Osame M, Igata A. Neuroophthalmological abnormalities in HTLV-I-associated myelopathy. Neuro-ophthalmology 1987; 7:243-248.
69. Yonenga Y, Arimura K, Suehara M, Arimura Y, Osame M. Electroencephalographic abnormalities in HTLV-I-associated myelopathy. Arch Neurol 1989; 46:513-516.
70. Arimura K, Arimura Y, Yonega Y, Rosales RL, Osame M. Clinical electrophysiologic findings in patients with HTLV-I-associated myelopathy (HAM). In: Roman G, Vernant JC, Osame M, editors. HTLV-I and the Nervous System. New York: Alan R Liss, 1989:245-250.
71. Bhigjee AI, Kelbe C, Haraibhai HC, Windsor IM, Hoffmann MH, Modi G, Bill PL, Becker WB, et al. Myelopathy associated with human T-cell lymphotrophic virus type I (HTLV-I) in Natal, South Africa. A clinical and investigative study in 24 patients. Brain 1990; 113:1307-1320.
72. Arimura K. Electrophysiologic studies on the peripheral nervous system of HTLV-I-associated myelopathy. Acta Med Univ Kagoshima 1987; 29:7-11.
73. Arimura K, Arimura Y, Moritoyo H, Tokimura Y, Takenaga S, Sonoda Y, Yamanaka H, Nakagawa M, et al. How helpful is thoracic paraspinal EMG in HAM/TSP? Muscle Nerve 1995; 18:248-250.
74. Vernant JC, Maurs L, Gout O, Buisson G, Plumelle Y, Neisson-Venant C, Monplaisir N, Roman GC. HTLV-I-associated tropical spastic paraparesis in Martinique: a reappraisal. Ann Neurol 1988; 23:Suppl: S133-135.
75. Osame M, Igata A, Matsumoto M. HTLV-I-associated myelopathy (HAM) revisited. In: Roman G, Vernant JC, Osame M, editors. HTLV-I and the Nervous System. New York: Alan R Liss, 1989.
76. Matsuo H, Nakamura T, Tsujihata M, Kinoshita I, Satoh A, Tomita I, Shirabe S, Shibayama K, et al. Plasmapheresis in treatment of human T-cell lymphotrophic virus type-I associated myelopathy. Lancet 1988; 2:1109-1113.
77. Matsuo H, Nakamura T, Shibayama K, Nagasato K, Tsujihata M, Nagataki S. Long-term follow-up of immunodilation in treatment of HTLV-I-associated myelopathy (HAM). Lancet 1989; 1:790.
78. Izumo S, Usuku K, Osame M, Arimura K, Igata A. Effect of ct-interferon treatment of HTLV-I-associated myelopathy (HAM). Neurology 1988; 39(suppl):242.
79. Harrington W, Sheremata W, Snodgrass S, Emerson S, Phillips S, Berger J. Tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses 1991; 7:1031-1034.
80. Kataoka A, Imai H, Inayoshi S, Tsuda T. Intermittent high-dose vitamin C therapy in patients with HTLV-I-associated myelopathy. J Neurol Neurosurg Psychiatry 1993; 56:1213-1216.
81. Takatsuki K, Yamaguchi K, Matsuoka M. ATLL and HTLV-I related diseases. In: Takatsuki K, editor. Adult T-cell Leukemia. Oxford: Oxford University Press, 1994: 1-27.
82. Matutes E, Brito-Babapulle V, Catovsky D. Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphoma. In: Miwa M, Sugano H, Sugimura T, Weiss A, editors. Retroviruses in Human Lymphoma/Leukemia. Tokyo: Japan Scientific Societies Press, 1985: 59-70.
83. Blattner WA, Nomur A, JClark JW, Ho GY, Nakao Y, Gallo R, Robert-Guroff M. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc Natl Acad Sci USA 1986; 83:4895-4898.
84. Yamaguchi K, Matutes E, Catovsky D, Galton DA, Nakada K, Takatsuki K. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. Lancet 1987; 2:94-95.
85. Yamamoto S, Hattori T, Asou N, Nishimura H, Kawano F, Yodoi J, Takatsuki K. Absolute neutrophilia in adult T cell leukemia. Jpn J Cancer Res 1986; 77:858-861.
86. Vukelja SJ, Weiss RB, Perry DJ, Longo DL. Eosinophilia associated with adult T cell leukemia/lymphoma. Cancer 1988; 62:1527-1530.
87. 2-microglobulin levels in adult T-cell leukemia. Int J Hematol 1992; 55:179-187.
88. Yasuda N, Lai PK, Ip SH, Kung PC, Hinuma Y, Matsuoka M, Hattori T, Takatsuki K, et al. Soluble IL-2 receptors in the sera of Japanese patients with adult T-cell leukemia mark activity of disease. Blood 1988; 71:1021-1026.
89. Yamaguchi K, Nishimura Y, Kiyokawa T, Takatsuki K. Elevated serum levels of soluble IL-2 receptors in HTLV-I-associated myelopathy. J Lab Clin Med 1989; 114:407-410.
90. Chosa T, Hattori T, Matsuoka M, Yamaguchi K, Yamamoto S, Takatsuki K. Analysis of anti-HTLV-I antibodies by strip radioimmunoassay - comparison with indirect immunofluorescence assay. Leuk Res 1986; 10:605-610.
91. Kiyokawa T, Yamaguchi K, Takeya M, Takahashi K, Watanabe T, Matsumoto T, Lee SY, Takatsuki K. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia. Cancer 1987; 59:1187-1191.
92. Wano Y, Hattori T, Matsuoka M, Takatsuki K, Chua AO, Gubler U, Greene WC. IL-1 gene expression in adult T-cell leukemia. J Clin Invest 1987; 80:911-916.
93. Niitsu Y, Urushizaki Y, Koshida Y, Terui K, Mahara K, Hohgo Y, Urushizaki I. Expression of TGF-β gene in adult T cell leukemia. Blood 1988; 17:263-266.
94. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987; 237:893-896
95. Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T-cell leukemia virus type 1 (HTLV-I) carriers and adult T cell leukemia that can be trans-activated by HTLV-I tax gene. J Exp Med 1990; 172:759-765.
96. Kinoshita T, Shimoyama M, Tobinai K, Ito M, Ikeda S, Tajima K, Shimotohno K, et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86:5620-5624.
97. Bilezikian JP, Etiologies and therapy of hypercalcemia. Endocrinol Metab Clin North Am 1989; 18:389-414.
98. Minato K, Hanada S. An interim report of LSG4 treatment for advanced peripheral T-cell lymphoma. Int J Hematol 1991; 54:179.
99. Daenen S, Rojer RA, Smit JW, Halie MR, Nieweg HO. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukemia. Br J Haematol 1984; 58:723-727.
100. Yamaguchi K, Yul LS, Oda T, Maeda Y, Ishii M, Fujita K, Kagiyama S, Nagai K, et al. Clinical consequences of 2′-deoxycoformycin treatment in patients with refractory adult T-cell leukemia. Leuk Res 1986; 10:989-993.
101. Waidmann TA, White JD, Goldman CK, Top L, Grant A, Bamford R, Roessler E, Horak ID, et al. The IL-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotropic virus I-induced adult-T-cell leukemia. Blood 1993; 82:1701-1712.
102. Waldmann TA. New approaches to the treatment of ATLL. In: Takatsuki K, editor. Adult T-Cell Leukemia. Oxford: Oxford University Press, 1994: 222-238.
103. Oguma S, Imamura Y, Kusumoto Y, Nishimura Y, Yamaguchi K, Takatsuki K, Tokudome S, Okuma M. Accelerated declining tendency of human T-cell leukemia virus type I carrier rates among younger blood donors in Kumamoto, Japan. Cancer Res 1992; 52:2620-2623.
104. Sweet RD. A pattern of eczema in Jamaica. Br J Dermatol 1966; 78:93-100.
105. Lagrenade L, Manns A, Fletcher V, Derm D, Carberry C, Hanchard B, Maloney EM, Cranston B, Williams NP, Wilks R, Kang EC, Blattner WA. Clinical, pathologic, immunologic features of human T-lymphotropic virus type 1-associated infective dermatitis in children. Arch dermatol 1998; 134:439-444.
106. Manns A, Hisada M, Lagrenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353:1951-1958.
107. Hanchard B, La grenade L, Carberry C, Fletcher B, Williams E, Cranston B, Blattner WA, Manns A. Childhood infective dermatitis evolving into adult C-cell leukaemia after 17 years. Lancet 1991; 338:1593-1594.
108. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N. HTLV-I uveids: a distinct clinical entity caused by HTLV-I. Jpn Cancer Res 1992; 83:236-239.
109. Mochizuki M, Watanabe T, Yamaguchi K, Yoshimura K, Nakashima S, Shirao M, Araki S, Takatsuki K, Mori S, Miyata N. Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol 1992; 114:123-129.
110. Kihara K,Tsuruda M, Ono A, Ikeda E, Hikita N, Miyata N, Mochizuki M. Human T-lymphotropic virus type-I uveitis in children. Nippon Ganka Gakkai Zasshi 1997; 101:538-543, J Jpn Ophthalmol Soc 1997; 101:538-543.
111. Kihara K,Tsuruda M, Ono A, Ikeda E, Hikita N, Miyata N, Mochizuki M. Human T-lymphotropic virus type-I uveitis in children. Nippon Ganka Gakkai Zasshi 1997; 101:538-543, J Jpn Ophthalmol Soc 1997; 101:538-543.
112. Remesar MC, Del Pozo AE, Pittis MG, Mangano AM, Sen L, Briones L. Transmission of HTLV-I by kidney transplant. Transfusion 2000; 40:1421-1422.
113. Nakatsuji Y, Sugai F, Watanabe S, Kaido M, Koguchi K, Abe K, Sakoda S. HTLV-I associated myelopathy manifested after renal transplantation. J Neurol Sci 2000; 177:154-156.
114. Toro C, Rodes B, Poveda E, Soriano V. Rapid development of subacute myelopathy in 3 organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003; 75:102-104.
115. Osman HK. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus Type I from a single donor. Analyses and commentaries. Transplantation 2003; 75:1-2.
116. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/Lymphadenopathy-associated virus in the workplace. MMWR 1985; 34:682-686, 691-695.
117. Centers for Disease Control. Current trends recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR 1986; 35:321-323.
118. Centers for Disease Control. Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001; 50(RR11):1-42.
119. Ichimaru M, Ikeda S, Kinoshita K, Hino S, Tsagi Y. Mother-to-child transmission of HTLV-I. Cancer Detect Prev 1991; 15:172-181.
120. Miyoshi I, Yoshimoto S, Kubonishi I, Fujishita M, Ohtsuki Y, Yamashita M, Yamato K, Hirose S, et al. Infectious transmission of human T-cell leukemia virus to rabbits. Int J Cancer 1985; 35:81-85.
121. Suga T, Kameyama T, Kinoshita T, Shimotohno K, Matsumura M, Tanaka H, Kushida S, Ami Y, et al. Infection of rats with HTLV-I: a small-animal model for HTLV-I carriers. Int J Cancer 1991; 49:764-769.
122. Shida H, Tochikura T, Sato T, Konno T, Hirayoshi K, Seki M, Ito Y, Hatanaka M, et al. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J 1987; 6:3379-3384.
123. Sawada T, Iwahara Y, Ishii K, Tagachi H, Hoshino H, Miyoshi I. Immunoglobulin prophylaxis against milkborne transmission of human T-cell leukemia virus type I in rabbits. J Infect Dis 1991; 164:1193-1196.
124. Gallo RC, The first human retrovirus. Sci Am 1986; 255:88-98.
125. Gray GS, White M, Bartman T, Mann D. Envelope gene sequence of HTLV-I isolate MT-2 and its comparison with other HTLV-I isolates. Virology 1990; 177:391-395.
126. Komarian F, Pelloquin F, de Thé G. In vivo genomic variability of HTLV-I depends more upon geography than pathologies. J Virol 1991; 65:3770-3778.
127. Schulz TF, Calabro M-L, Hoad JG, Carrington CV, Matutes E, Catovsky D, Weiss RA. HTLV-I envelope sequences from Brazil and Caribbean, and Romania. Clustering of sequences according to geographic origin and variability in an antigenic epitope. Virology 1991; 184:483-491.
128. Sherman MP, Saksena NK, Dube DK, Yanagihara R, Poiesz BJ. Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol 1992; 66:2556-2563.
129. Clapham P, Nagy K, Weiss RA. Pseudotypes of human T-cell leukemia virus types I and II: neutralization by patients' sera. Proc Natl Acad Sci USA 1984; 81:2886-2889.
130. Hoshino H, Clapham PR, Weiss RA, Miyoshi I, Yoshida M, Miwa M. Human T-cell leukemia virus type I. Pseudotype neutralization of Japanese and American isolates with human and rabbit sera. Int J Cancer 1985; 36:671-675
131. Osterhaus A, Weljer K, Uytdehaug F, Jarrett O, Sundquist B, Morein B. Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOM. J Immunol 1985; 135:591-596.
132. Marciani DJ, Kensii CR, Beltz GA, Hung C, Cronier J, Auber A. Genetically engineered subunit vaccine against feline leukemia virus: protective immune response in cats. Vaccine 1991; 9:89-96.
133. Cotter SM, Feline leukemia virus: pathophysiology, prevention, and treatment. Cancer Invest 1992; 10:173-181.